Rajesh Chopra
Algemeen Directeur bij Aethon Therapeutics, Inc.
Oorsprong van het eerstegraads netwerk van Rajesh Chopra
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
84
| Subsidiary | Biotechnology | 84 |
Public Company | Pharmaceuticals: Major | 55 | |
Apple Tree venture Managemnet Llc//vc
Apple Tree venture Managemnet Llc//vc Investment ManagersFinance Apple Tree venture Managemnet LLC (Apple Tree Partners) is a venture capital firm founded by Seth Harrison in 1999. The firm is headquartered in New York with an additional offices in London, San Francisco and Cambridge.
26
| Private Company | Investment Managers | 26 |
Artios Pharma Ltd.
Artios Pharma Ltd. Pharmaceuticals: MajorHealth Technology Artios Pharma Ltd. manufactures pharmaceutical products. The firm develops a DNA Damage Response (DDR) is a cancer therapy. The company was founded by Niall Martin in May 2016 and is headquartered in London, the United Kingdom.
19
| Holding Company | Pharmaceuticals: Major | 19 |
Nereid Therapeutics, Inc.
Nereid Therapeutics, Inc. BiotechnologyHealth Technology Nereid Therapeutics, Inc. operates as a life sciences venture firm. It translates the potential of biomolecular condensates into life-changing therapeutics. The company was founded by Clifford Brangwynne and Spiros Liras and is headquartered in Cambridge, MA.
8
| Holding Company | Biotechnology | 8 |
Public Company | Biotechnology | 4 | |
Aethon Therapeutics, Inc.
Aethon Therapeutics, Inc. Hospital/Nursing ManagementHealth Services Part of NYU Langone Medical Center, Aethon Therapeutics, Inc. is a company that provides services available through their website. The company is based in New York, NY. The company uses cookies to enhance the user's experience and provide essential website cookies. The CEO of the company is Rajesh Chopra.
3
| Subsidiary | Hospital/Nursing Management | 3 |
The UCL Academy
1
| College/University | Other Consumer Services | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Rajesh Chopra via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
Princeton University | College/University | Director/Board Member Undergraduate Degree Undergraduate Degree Undergraduate Degree Graduate Degree Undergraduate Degree | |
BIOGEN INC. | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO Sales & Marketing Chief Tech/Sci/R&D Officer Corporate Officer/Principal Director/Board Member | |
Marengo Therapeutics, Inc.
Marengo Therapeutics, Inc. BiotechnologyHealth Technology Marengo Therapeutics, Inc. operates as a biotechnology company that develops immunotherapies. Its product is Universal Targeted Immunotherapy a drug discovery platform that underpins an immunological tumor elimination. The company was founded by Andreas Loew and is headquartered in Cambridge, MA. | Biotechnology | Chairman Director/Board Member Director/Board Member Director/Board Member Corporate Officer/Principal | |
University of Oxford | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree Doctorate Degree Doctorate Degree | |
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer | |
Zeneca Pharmaceuticals
Zeneca Pharmaceuticals Pharmaceuticals: MajorHealth Technology Zeneca Pharmaceuticals manufactures medicines. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal Chief Operating Officer | |
Replicate Bioscience, Inc.
Replicate Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Replicate Bioscience, Inc. is a clinical-stage biopharmaceutical company based in San Diego, CA. The company focuses on creating novel oncology treatments to prevent drug resistance using its synrgy technology. Replicate aims to enhance the effectiveness of many immuno-oncology regimens in early stages of care and is developing its own pipeline of immuno-oncology products in breast, lung, and prostate cancers. Replicate is differentiated by a team of srrna experts, a customizable library of synthetic srrna vectors, and end-to-end development capabilities. The company harnesses the body's natural protein-making power and uses synthetic biology to design unique self-replicating rnas (srrnas) that can direct that power to fight disease. The company was founded by Nathaniel Whang, Zachary Hartman, Michael D. Ehlers, Herbert Kim Lyerly, Andrew J. Geall, and Nathaniel Whang has been the CEO since incorporation. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Founder Director/Board Member | |
Ascidian Therapeutics, Inc.
Ascidian Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ascidian Therapeutics, Inc. operates as a biotechnology research and development company. The company is headquartered in Brighton, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Executive Officer Chief Tech/Sci/R&D Officer | |
Nine Square Therapeutics, Inc.
Nine Square Therapeutics, Inc. BiotechnologyHealth Technology Nine Square Therapeutics, Inc. provides biotechnology services. The company was founded in 2020 and is headquartered in New York, NY. | Biotechnology | Director/Board Member Director/Board Member Founder Chief Executive Officer | |
Galvanize Therapeutics, Inc.
Galvanize Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Galvanize Therapeutics, Inc. operates as a biotechnology firm. The company was founded in 2020 and is headquartered in Menlo Park, CA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Chief Executive Officer Director/Board Member | |
BRAEBURN INC. | Miscellaneous Commercial Services | Chairman Director/Board Member Director/Board Member Private Equity Investor | |
Aulos Bioscience, Inc.
Aulos Bioscience, Inc. BiotechnologyHealth Technology Aulos Bioscience, Inc. operates as a biotechnology firm. The company is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Chairman | |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member Corporate Officer/Principal | |
European Federation of Pharmaceutical Industries & Assns
European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member President President | |
SANOFI | Biotechnology | Director/Board Member Chief Executive Officer Director/Board Member Corporate Officer/Principal | |
Leerink Partners LLC
Leerink Partners LLC Investment Banks/BrokersFinance Leerink Partners LLC is a full-service brokerage and investment banking firm headquartered in Boston, Massachusetts. The firm was founded by Jeffrey Leerink in 1995 and formerly known as SVB Securities LLC. They rebranded as Leerink Partners in 2023. The firm is a subsidiary of SVB Securities LLC. Leerink Partners provides institutional sales, equity research, institutional trading, and corporate finance and asset management services to the healthcare and technology industries. They offer superior execution capabilities in common stock, convertibles and derivatives with a singular focus on healthcare and a knowledge-led approach. | Investment Banks/Brokers | Consultant / Advisor Analyst-Equity Analyst-Equity | |
University of London | College/University | Doctorate Degree Graduate Degree Doctorate Degree | |
The Royal College of Physicians | College/University | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
AGIOS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chairman Director of Finance/CFO | |
University of Cambridge | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree | |
AstraZeneca, Inc.
AstraZeneca, Inc. BiotechnologyHealth Technology Part of AstraZeneca PLC, AstraZeneca, Inc. manufactures vaccines. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer Chief Operating Officer | |
Intergalactic Therapeutics, Inc.
Intergalactic Therapeutics, Inc. BiotechnologyHealth Technology Intergalactic Therapeutics, Inc. is a gene therapy company based in Baltimore, MD. The company is revolutionizing gene therapies with a novel non-viral platform comprised of its versatile synthetic and episomal c3dna molecules. The company uses a customized approach to focal therapeutic delivery using its lead delivery technology, the comet pulsed electric field system, and a proprietary cell-free manufacturing process invented to make gene therapy safer and more accessible for patients. With programs in ophthalmology, oncology, respiratory diseases, and expansion areas including CNS, renal, and musculoskeletal, Intergalactic Therapeutics is dedicated to transforming genetic medicine. The company was founded by Michael D. Ehlers, and Theresa G. H. Heah has been the CEO of the company since 2023. | Biotechnology | Director/Board Member Director/Board Member Founder | |
Apertor Pharmaceuticals, Inc.
Apertor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Apertor Pharmaceuticals, Inc. manufactures pharmaceutical products. | Pharmaceuticals: Major | Director/Board Member President Director/Board Member | |
PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Private Equity Investor | |
AVALO THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member | |
Initial Therapeutics Inc
Initial Therapeutics Inc BiotechnologyHealth Technology Opal Biosciences, Inc. operates as a biotechnology company. The company is headquartered in New York, NY. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
Yale University | College/University | Undergraduate Degree Graduate Degree Masters Business Admin | |
Third Rock Ventures LLC
Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor | |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Private Equity Investor | |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree | |
California Institute of Technology
California Institute of Technology Other Consumer ServicesConsumer Services California Institute of Technology provides education focusing on science, engineering, academia, business, and public service. The company was founded in 1891 and it is headquartered in Pasadena, CA. | College/University | Director/Board Member Undergraduate Degree Undergraduate Degree | |
JUNO THERAPEUTICS INC | Biotechnology | Director/Board Member Director/Board Member Treasurer | |
Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
Bunge Ltd.
Bunge Ltd. Agricultural Commodities/MillingProcess Industries Bunge Global SA operates as a holding company. engages in the supply and transportation of agricultural commodities. It operates through the following segments: Agribusiness, Refined and Specialty Oils, Milling, and Sugar and Bioenergy. The Agribusiness segment is involved in the purchase, storage, transportation, processing, and sale of agricultural commodities and commodity products. The Refined and Specialty Oils segment engages in the processing, production, and marketing of products derived from vegetable oils. The Milling segment consists of the processing, production, and marketing of products derived primarily from wheat and corn. The Sugar and Bioenergy segment includes the manufacture and marketing of sugar and ethanol derived from sugarcane, as well as energy derived from the sugar and ethanol production process. The company was founded by Johann Peter Gottlieb Bunge in 1818 and is headquartered in St. Louis, MO. | Agricultural Commodities/Milling | Director/Board Member Director of Finance/CFO Comptroller/Controller/Auditor | |
The Johns Hopkins University School of Medicine | College/University | Doctorate Degree Doctorate Degree Corporate Officer/Principal | |
SMITH & NEPHEW PLC | Medical Specialties | Director/Board Member Director/Board Member Director of Finance/CFO | |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Public Communications Contact Sales & Marketing Corporate Officer/Principal | |
Idorsia Pharmaceuticals Ltd.
Idorsia Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Idorsia Ltd., Idorsia Pharmaceuticals Ltd. is a Swiss company that aims to discover, develop, and provide innovative medicines to patients. The company is based in Allschwil, Switzerland. The company has created an eBook that provides useful information about Fabry disease, a rare inherited disorder caused by the build-up of a fat-like substance in the cells of the body organs. Jean-Paul Clozel has been the CEO of the company since 2017. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
RECEPTOS INC | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO | |
Smith & Nephew A/S (Denmark)
Smith & Nephew A/S (Denmark) Medical SpecialtiesHealth Technology Smith & Nephew A/S operates as a is a global medical technology business. It specializes in healthcare, medical supplies, medical devices, wound care, orthopaedic reconstruction and sports medicine. The company was founded by Thomas James Smith in 1856 and is headquartered in Horsholm, Denmark. | Medical Specialties | Director/Board Member Director of Finance/CFO | |
Massachusetts Institute of Technology | College/University | Corporate Officer/Principal Doctorate Degree | |
Stanford University | College/University | Doctorate Degree Undergraduate Degree | |
Biogen Idec, Inc. (North Carolina)
Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016. | Pharmaceuticals: Major | Chairman Director of Finance/CFO | |
Amherst College | College/University | Undergraduate Degree Undergraduate Degree | |
Upstream Bio, Inc.
Upstream Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Upstream Bio, Inc. is a clinical-stage biopharmaceutical company based in Waltham, MA, USA. The American company's lead program, upb-101, is a monoclonal antibody that inhibits the TSLP receptor, a validated target that affects various immune cells involved in common and rare diseases. Upstream Bio is leveraging its diverse roots and substantial industry experience to develop therapies that ease the burden of inflammatory and allergic diseases on patients and their loved ones. The company was founded by Eran Perry and Earn Perry, and Samantha Truex has been the CEO since 2021. | Miscellaneous Commercial Services | Director/Board Member Chief Executive Officer | |
Calliditas Therapeutics Suisse SA
Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Calliditas Therapeutics Suisse SA engages in the development of NOX therapies. Its platform enables the identification of orally available small-molecules that selectively inhibit specific NOX enzymes, which amplify multiple disease processes such as fibrosis, inflammation, pain processing, cancer development, and neurodegeneration. The company was founded Chihiro Yabe, Robert A. Clark, David Lambeth, and Karl-Heinz Krause in 2006 and is headquartered in Geneva, Switzerland. | Pharmaceuticals: Generic | Director of Finance/CFO Director/Board Member | |
McKinsey & Co., Inc. (United Kingdom)
McKinsey & Co., Inc. (United Kingdom) Investment ManagersFinance Part of McKinsey & Co., Inc., McKinsey & Co., Inc. (United Kingdom) is a consulting firm that helps UK manufacturers embrace new technologies for digital transformation and leadership. The company is based in London, UK. Ruben Schaubroeck, McKinsey Digital's new lead for the UK, Belgium, and Netherlands offices, spoke with Thomas Farrar, a manager of communications in the firm's UK office, about the importance of speed and pace for CEOs in this new growth journey. The British company works with organizations that pursue sustainability, inclusion, and economic growth, all at the same time, to achieve strategic foresight and built-in agility in the face of the COVID-19 pandemic and the new trading relationship with the EU. | Investment Managers | Corporate Officer/Principal Director/Board Member | |
Oak Investment Partners
Oak Investment Partners Investment ManagersFinance Oak Investment Partners (Oak Investment Partners) is a venture capital firm founded in 1978 by Ed F Glassmeyer and Stewart H Greenfield. The firm is headquartered in Wilton, Connecticut. | Investment Managers | Corporate Officer/Principal Corporate Officer/Principal | |
RITE AID CORPORATION | Drugstore Chains | Chief Administrative Officer Director/Board Member |
Statistieken
Internationaal
Verenigde Staten | 39 |
Verenigd Koninkrijk | 7 |
Frankrijk | 3 |
Zwitserland | 3 |
België | 2 |
Sectoraal
Health Technology | 26 |
Consumer Services | 14 |
Commercial Services | 6 |
Finance | 6 |
Process Industries | 2 |
Operationeel
Director/Board Member | 655 |
Corporate Officer/Principal | 250 |
Chairman | 183 |
Independent Dir/Board Member | 159 |
Chief Executive Officer | 91 |
Sterkste connecties
Insiders | |
---|---|
Raphaël Wisniewski | 45 |
Pierre Legault | 45 |
Seth Harrison | 43 |
Argeris Karabelas | 42 |
Perry Karsen | 38 |
Trevor Jones | 36 |
Barbara Dalton | 35 |
Chen-Ming Yu | 33 |
Rodman L. Drake | 33 |
Michael Bonney | 32 |
Sol Barer | 32 |
Michael Friedman | 30 |
René Kuijten | 30 |
Thomas Fulton Wilson McKillop | 28 |
Richard W. Barker | 26 |
- Beurs
- Insiders
- Rajesh Chopra
- Bedrijfsconnecties